Pulmonary Disease, Chronic Obstructive Clinical Trial
— iTrainOfficial title:
Long-Term Integrated Telerehabilitation of COPD Patients. A Multi-Center Randomized Controlled Trial
Verified date | April 2019 |
Source | University Hospital of North Norway |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research project aims to conduct a three-arm multi-center randomized controlled trial (RCT) on an innovative telerehabilitation intervention for patients with chronic obstructive pulmonary disease (COPD). The overall purpose of the RCT is to demonstrate whether long-term integrated telerehabilitation involving exercise training at home, telemonitoring, and education/self-management will prevent hospital readmissions, thus reducing healthcare costs, for patients with COPD, and will improve patient status and quality of life.
Status | Completed |
Enrollment | 120 |
Est. completion date | December 2018 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of COPD - At least one COPD-related hospitalization or COPD-related emergency department presentation in the previous 12 months to enrollment - Capable to provide signed written informed consent Exclusion Criteria: - Attendance to a rehabilitation program in the previous 6 months of enrollment - Participation in another study that may have an impact on the outcome of this study - Deemed by the health care team to be physically uncapable to perform the study procedures - Presence of comorbidities wich might prevent the patient from safely undertake an exercise program at home - Home environment not suitable for installation and use of rehabilitation and monitoring equipment (e.g. physical space, Wi-FI Internet or mobile Internet via 4G) |
Country | Name | City | State |
---|---|---|---|
Australia | The Alfred | Melbourne | Victoria |
Denmark | Sydvestjysk Hospital | Esbjerg | |
Norway | University Hospital of North Norway | Tromsø |
Lead Sponsor | Collaborator |
---|---|
University Hospital of North Norway | Aalborg University, Esbjerg Municipality, La Trobe University, LHL Helse, Sydvestjysk Hospital, The Alfred, The Research Council of Norway, The Royal Norwegian Ministry of Health, University of Tromso |
Australia, Denmark, Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change from baseline in BODE Index at 6 months | 6 months | ||
Other | Change from baseline in BODE Index at 1 year | 1 year | ||
Other | Change from baseline in BODE Index at 2 years | 2 years | ||
Primary | Combined number of hospitalizations and emergency department presentations | Two years | ||
Secondary | Hospitalizations | Two years | ||
Secondary | Emergency department presentations | Two years | ||
Secondary | Mortality | Two years | ||
Secondary | Time free from first hospitalization or emergency department presentation | Two years | ||
Secondary | Cost-effectiveness | Cost-Utility Analysis (Cost/QALY) | Two years | |
Secondary | Change from baseline in COPD Assessment Test at 6 months | 6 months | ||
Secondary | Change from baseline in COPD Assessment Test at 1 year | One year | ||
Secondary | Change from baseline in COPD Assessment Test at 2 years | Two years | ||
Secondary | Change from baseline in EQ-5D at 6 months | Six months | ||
Secondary | Change from baseline in EQ-5D at 1 year | One year | ||
Secondary | Change from baseline in EQ-5D at 2 years | Two years | ||
Secondary | Change from baseline in Hospital Anxiety and Depression Scale at 6 months | Six months | ||
Secondary | Change from baseline in Hospital Anxiety and Depression Scale at 1 year | One Year | ||
Secondary | Change from baseline in Hospital Anxiety and Depression Scale at 2 years | Two years | ||
Secondary | Change from baseline in Generalized Self-Efficacy Scale at 6 months | Six months | ||
Secondary | Change from baseline in Generalized Self-Efficacy Scale at 1 year | One year | ||
Secondary | Change from baseline in Generalized Self-Efficacy Scale at 2 years | Two years | ||
Secondary | Change from baseline in 6- minute walking distance at 6 months | Six months | ||
Secondary | Change from baseline in 6- minute walking distance at 1 year | One year | ||
Secondary | Change from baseline in 6- minute walking distance at 2 years | Two years | ||
Secondary | Change from baseline in physical activity at 6 months | Six months | ||
Secondary | Change from baseline in physical activity at 1 year | One year | ||
Secondary | Change from baseline in physical activity at 2 years | Two years | ||
Secondary | Patient Global Impression of Change after 2 years | Two years | ||
Secondary | Hospitalizations at 1 year | One year | ||
Secondary | Emergency department presentations at 1 year | One year | ||
Secondary | Mortality at 1 year | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|